Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew J Adams

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Blood Cancer Discovery|November 20, 2025
Nuclear Export Gone Rogue: XPO1's Chromatin Side Hustle Fuels LeukemiaDrew J Adams
ACS Chemical Biology|June 15, 2017
2-Chloropropionamide As a Low-Reactivity Electrophile for Irreversible Small-Molecule Probe IdentificationDharmaraja Allimuthu, Drew J Adams
Trends in Pharmacological Sciences|December 6, 2024
Therapeutic targeting of exportin-1 beyond nuclear exportYi Fan Chen, Drew J Adams
Nature Chemical Biology|August 22, 2022
The landscape of targets and lead molecules for remyelinationAndrew V Caprariello, Drew J Adams
ACS Chemical Biology|June 12, 2026
Mass Spectrometry-Based Screening Reveals Inhibitors of Cholesterol 25-HydroxylaseAtikur Rahman, Elijah H Hayes, Drew J Adams
The FEBS Journal|April 21, 2026
Redirecting TRIM21 with TRIMTACs for the targeted degradation of multimeric proteinsMarc A Scemama de Gialluly, Drew J Adams
Journal of the American Chemical Society|April 27, 2012
Progress toward the syntheses of (+)-GB 13, (+)-himgaline, and himandridine. new insights into intramolecular imine/enamine aldol cyclizationsDavid A Evans, Drew J Adams, Eugene E Kwan
ACS Chemical Biology|July 7, 2021
Screening Reveals Sterol Derivatives with Pro-Differentiation, Pro-Survival, or Potent Cytotoxic Effects on Oligodendrocyte Progenitor CellsJoel L Sax, Zita Hubler, Dharmaraja Allimuthu, et al.
Seminars in Radiation Oncology|September 19, 2015
Radiotherapy in the Era of Precision MedicineBrian Yard, Eui Kyu Chie, Drew J Adams, et al.
ACS Chemical Biology|March 20, 2024
Lipid-Restricted Culture Media Reveal Unexpected Cancer Cell SensitivitiesRalston B Goldfarb, Matthew J Atala Pleshinger, David F Yan, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Blood Cancer Discovery|November 20, 2025
Nuclear Export Gone Rogue: XPO1's Chromatin Side Hustle Fuels LeukemiaDrew J Adams
ACS Chemical Biology|June 15, 2017
2-Chloropropionamide As a Low-Reactivity Electrophile for Irreversible Small-Molecule Probe IdentificationDharmaraja Allimuthu, Drew J Adams
Trends in Pharmacological Sciences|December 6, 2024
Therapeutic targeting of exportin-1 beyond nuclear exportYi Fan Chen, Drew J Adams
Nature Chemical Biology|August 22, 2022
The landscape of targets and lead molecules for remyelinationAndrew V Caprariello, Drew J Adams
ACS Chemical Biology|June 12, 2026
Mass Spectrometry-Based Screening Reveals Inhibitors of Cholesterol 25-HydroxylaseAtikur Rahman, Elijah H Hayes, Drew J Adams
The FEBS Journal|April 21, 2026
Redirecting TRIM21 with TRIMTACs for the targeted degradation of multimeric proteinsMarc A Scemama de Gialluly, Drew J Adams
Journal of the American Chemical Society|April 27, 2012
Progress toward the syntheses of (+)-GB 13, (+)-himgaline, and himandridine. new insights into intramolecular imine/enamine aldol cyclizationsDavid A Evans, Drew J Adams, Eugene E Kwan
ACS Chemical Biology|July 7, 2021
Screening Reveals Sterol Derivatives with Pro-Differentiation, Pro-Survival, or Potent Cytotoxic Effects on Oligodendrocyte Progenitor CellsJoel L Sax, Zita Hubler, Dharmaraja Allimuthu, et al.
Seminars in Radiation Oncology|September 19, 2015
Radiotherapy in the Era of Precision MedicineBrian Yard, Eui Kyu Chie, Drew J Adams, et al.
ACS Chemical Biology|March 20, 2024
Lipid-Restricted Culture Media Reveal Unexpected Cancer Cell SensitivitiesRalston B Goldfarb, Matthew J Atala Pleshinger, David F Yan, et al.
Pageof 5